# US 2007/0037166 A1 · Methods and compositions for diagnosing and monitoring transplant rejection

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2007/0037166 A1
- Document ID: US20070037166A1
- Status: Published application
- Kind: A1
- Application number: 10/990,275
- Filed: 2004-11-15
- Published: 2007-02-15
- Earliest claimed: 2001-06-08
- Assignees: Expression Diagnostics, Inc.
- Inventors: Jay Wohlgemuth; Kirk Fry; Robert Woodward; Ngoc Ly
- Web page: https://patentgrep.com/patent/US20070037166A1

## CPC

- C12Q 1/6883: for diseases caused by alterations of genetic material
- C12Q 2600/158: Expression markers
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Methods of diagnosing or monitoring transplant rejection or cytomegalovirus infection in a patient by detecting the expression level of one or more genes or surrogates derived therefrom in the patient are described. Diagnostic oligonucleotides for diagnosing or monitoring transplant rejection or cytomegalovirus infection and kits or systems containing the same are also described.

## Claims

### Claim at position 1

1-35. (canceled)

### Claim 36

A method of diagnosing or monitoring transplant rejection in a patient, comprising detecting the expression level of one or more genes in said patient to diagnose or monitor transplant rejection in said patient wherein said one or more genes comprise a nucleotide sequence selected from the group consisting of SEQ ID NO: 2127, SEQ ID NO: 2011, SEQ ID NO: 2762, SEQ ID NO: 4565, SEQ ID NO: 7295, SEQ ID NO: 5038, SEQ ID NO: 2421, SEQ ID NO: 3080, SEQ ID NO: 2347 and SEQ ID NO: 269.

### Claim 37 (depends on 36)

The method of claim 36 wherein said transplant rejection is cardiac transplant rejection.

### Claim 38 (depends on 36)

The method of claim 36 wherein said expression level is detected by measuring the RNA level expressed by said one or more genes.

### Claim 39 (depends on 38)

The method of claim 38, further including isolating RNA from said patient prior to detecting said RNA level expressed by said one or more genes.

### Claim 40 (depends on 38)

The method of claim 38 wherein said RNA level is detected by PCR.

### Claim 41 (depends on 38)

The method of claim 38 wherein said RNA level is detected by hybridization.

### Claim 42 (depends on 38)

The method of claim 38 wherein said RNA level is detected by hybridization to an oligonucleotide.

### Claim 43 (depends on 42)

The method of claim 42 wherein said oligonucleotide comprises DNA, RNA, cDNA, PNA, genomic DNA, or synthetic oligonucleotides.
